CNBC's Simon Hobbs reports on all the market moving events in Europe today, including a really bad session for Greece and the French prime minister faces a parliamentary vote of confidence.» Read More
CNBC's Carl Quintanilla reports Italy, Spain and Germany are among this week's biggest gainers in Europe.
The ECB’s triple-interest rate cut and bond-buying announcement surprised investors on Thursday – and were still sparking debate a day on.
CNBC's Seema Mody reports on all the market moving events from Europe, as investors focus on the U.S. dollar - euro trade, and peace talks between Ukraine and Russia.
Stefano Scabbio, CEO of Mapower Italia and Iberia, says that in contrast to Italy, the Spanish labor market is seeing green shoots of recovery because it has implemented reforms.
CNBC's Michelle Caruso-Cabrera reports European markets closed higher across the board on Mario Draghi's move to cut interest rates, and purchase asset backed securities and covered bonds.
*Jackson Hole speech increases QE expectations. LONDON, Sept 4- Euro zone bond yields dipped on Thursday as the European Central Bank was expected to reinforce its message that it was ready to use all its tools, including bond-buying, to support the economy and lift inflation.
CNBC's Carl Quintanilla reports on all the market moving events in Europe today, including worries in Ukraine and falling Euro-zone PMI.
CNBC's Carl Quintanilla reports on all the market moving events in Europe today, including a decline for the euro ahead of Thursday's ECB meeting.
Dollar General sweetens Family Dollar bid, may go hostile. Dollar General Corp raises its bid for Family Dollar Stores Inc to $9.1 billion, and warns it may turn hostile and appeal directly to shareholders if the new offer is rejected.
BARCELONA, Sept 2- Though speculation is rife of a new Pfizer bid, AstraZeneca's chief executive is not holed up with advisers in London or New York. Strict British takeover rules limit what Soriot and other players can say about Pfizer's abortive attempt to buy AstraZeneca and the possibility of a resumption of talks.
LONDON- UK Treasury Chief Secretary Danny Alexander delivers speech setting out' his vision for Scotland to remain as an integral and full member of the United Kingdom' at Chatham House. MADRID- Central Bank of Peru Governor Julio Velarde speaks about monetary policy and macroeconomic stability at an event devoted to promoting investment in the country.
*Novartis's LCZ696 and PCSK9 drugs could treat millions. Hopes have spiked for a heart failure drug from Novartis and an innovative class of injectable anti-cholesterol agents known as PCSK9 inhibitors after the release of data at the ESC's annual meeting indicated that they can save more lives than standard therapies.
SANTANDER, Spain, Sept 1- Telefonica plans to exit Telecom Italia once the Spanish group has finalised the purchase of Vivendi's Brazilian broadband unit GVT, its chairman said on Monday, ending a long-standing shareholding.
*Novartis sees margins on LCZ696 better than for Diovan. BARCELONA, Sept 1- Sales forecasts for Novartis's new heart failure drug are being ramped up by analysts after strikingly good clinical trial results for a medicine doctors expect to transform treatment of the deadly disease.
*Sanofi, Regeneron vying with drugs from Amgen and Pfizer. BARCELONA, Aug 31- An experimental cholesterol-lowering drug from Sanofi and Regeneron Pharmaceuticals roughly halved the number of heart attacks and strokes in a clinical trial, researchers reported on Sunday.
BARCELONA, Aug 31- Swiss engineers, famous for making the world's finest watches, are turning their hands to cardiology with a prototype battery-less pacemaker based on a self-winding wristwatch.
LJUBLJANA- Bled Strategic Forum 2014 in Slovenia.
PARIS/ LONDON/ MILAN, Aug 29- Telecom Italia has lost a promising path to earnings growth by failing to secure Brazilian broadband business GVT and may now turn from hunter to hunted in a fast-consolidating telecoms industry.
CNBC's Simon Hobbs breaks down the performance of European stocks in the month of August, including an outperform for the German bond market.
*AstraZeneca shares up 2 percent. LONDON, Aug 29- Hopes for AstraZeneca's promising cancer drug pipeline were boosted on Friday by news the company had moved its immuno-oncology medicine MEDI-4736 into a mid-stage study in colorectal cancer.